Continuing Medical Education Accreditation: The American Urological Association Education and Research, Inc. (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AUAER takes responsibility for the content, quality, and scientific integrity of this CME activity.
Course Webcasts
Advanced Concepts in the Treatment of Erectile Dysfunction
Supported by an educational grant from
Overview
This advanced postgraduate course examines the causes and treatment modalities of erectile dysfunction (ED) most often seen by urologists. The diagnosis and treatment of ED has undergone a revolution in the past decade. New treatment modalities have emerged to assist both primary care physician and urologist in treating the large number of patients suffering from this difficult condition. With the advent of new oral medications it is important to understand the capabilities of these different phosphodiesterase-5 (PDE-5) inhibitors, their differences and the pharmacologic action of each agent. Because urologists are often confronted with the most difficult patients with ED, it is important for the urologist to understand the treatment of patients with ED associated with vascular disease, the difficulty in treating patients such as those following prostate cancer treatment whether by radiation or surgery and the initial medical treatment of Peyronie’s disease. This course will present the most recent data on oral medications recently marketed and compare the PDE-5 inhibitors, discuss new centrally acting agents soon to be available. Medical therapy of Peyronie’s disease and patients with severe ED following treatment of carcinoma of the prostate will be highlighted. Issues regarding patients who fail initial therapy with PDE-5 inhibitors will also be included. The concept of medical prophylaxis, change in PDE-5 inhibitors, combination therapy and more invasive treatment alternatives will be discussed. Case discussions on ED and the interaction of medications, common cardiovascular, neurologic and post-surgical conditions will facilitate faculty/audience interaction.
Objectives: After attending this course, the participants should be able to:
discuss the physiology and pathophysiology of erectile function and dysfunction in men at risk for this difficult condition
identify similarities, differences and outcomes with the various PDE-5 inhibitors currently available
treat patients with ED following management of carcinoma of the prostate
consider alternatives of medical treatment for patients with Peyronie’s disease
offer a series of approaches for patients with difficult to treat ED unresponsive to initial therapy with oral agents
Webcast Program
If you wish to apply for CME for these lectures, please log in first.
PDE Inhibitors: efficacy and safety update Jacob Rajfer, M.D. Professor, Department of Urology, University of California—Los Angeles (UCLA), Chief of Urology Harbor - UCLA Medical Center, Torrance, California
Physiology of Erection Jacob Rajfer, M.D. Professor, Department of Urology, University of California—Los Angeles (UCLA), Chief of Urology Harbor - UCLA Medical Center, Torrance, California
